For more than a quarter of a century, Mr. Rein has focused on patent litigation, strategic counseling and patent-related due diligence. As a result of his scientific background and IP expertise, he digs into the facts to come up with innovative legal solutions to complex problems, whether behind the scenes advising clients or in litigation on their behalf. See, e.g., Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc., 217 F.Supp.3d 782 (D. Del. 2016) (Trial victory relating to a generic version of NASONEX based on Mr. Rein’s examination of the parties’ expert witnesses including Merck’s expert who used one of the world’s most powerful X-ray diffraction facilities, the synchrotron at Argonne National Laboratory, in an unsuccessful attempt to prove infringement).
Prior to joining Goodwin in 2001 to help start its IP law practice in New York, Mr. Rein was a partner at a well-known IP law firm. Earlier in his career, he clerked at the U.S. District Court for the Central District of California (located in Los Angeles). He is currently serving his second term on the Patents Committee of the New York City Bar Association and is involved in both the Israel Practice committee of the American Intellectual Property Law Association (AIPLA) and the Tech Division committee of UJA. Mr. Rein has also undertaken pro bono work on behalf of The Legal Aid Society as well as legal educational work with the Anti-Defamation League.